InSphero AG

Info

InSphero is a leading supplier of organotypic 3D microtissues for highly predictive drug testing and disease modeling, with subsidiaries in USA and Germany

Geschichte

InSphero is a leading supplier of organotypic, biological microtissues for biomimetic drug testing. The company, headquartered in Zurich, Switzerland, currently collaborates with more than ten global pharmaceutical and cosmetics companies to implement the company’s patent-pending microtissue technology in the customer’s development work-flow. InSphero is a spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich and was founded in 2009 by Dr. Jan Lichtenberg, Dr. Jens Kelm, Dr. Wolfgang Moritz and Prof. Dr. Dr. Simon P. Hoerstrup. InSphero has its production, laboratory and office space at the Technopark in Zurich, Switzerland. InSphero was recognized for its scientific and commercial achievements with a number of awards, including the VentureKick award, Heuberger Entrepreneurial Award and CTIstartup certification.

InSphero’s founders combine more than 15 years of experience in microtissue engineering and over 10 years in microfluidics and laboratory automation with the goal to deliver highly functional, reliable and easy-to-use microtissues.

InSphero AG
Technoparkstrasse 1
CH-8005 Zurich
Switzerland

Tel.: +41-44-515049-0
Fax +41-44-515049-1

"InSphero sets the standard for in vitro drug discovery and safety testing with innovative 3D cell-based technology and comprehensive preclinical research solutions. Its robust and highly physiologically relevant suite of 3D InSight™ Platforms for liver toxicology, liver disease, diabetes, and oncology are used by major pharmaceutical biotechnology companies worldwide."